These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 25070999)

  • 1. Use of Japanese encephalitis vaccine in US travel medicine practices in Global TravEpiNet.
    Deshpande BR; Rao SR; Jentes ES; Hills SL; Fischer M; Gershman MD; Brunette GW; Ryan ET; LaRocque RC; The Global TravEpiNet Consortium
    Am J Trop Med Hyg; 2014 Oct; 91(4):694-698. PubMed ID: 25070999
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Japanese Encephalitis Vaccine: Recommendations of the Advisory Committee on Immunization Practices.
    Hills SL; Walter EB; Atmar RL; Fischer M;
    MMWR Recomm Rep; 2019 Jul; 68(2):1-33. PubMed ID: 31518342
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A survey of US travelers to Asia to assess compliance with recommendations for the use of Japanese encephalitis vaccine.
    Duffy MR; Reed C; Edelson PJ; Blumensaadt S; Crocker K; Griggs A; Biggerstaff BJ; Delorey MJ; Hayes EB; Fischer M
    J Travel Med; 2013; 20(3):165-70. PubMed ID: 23577862
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Japanese encephalitis vaccines: recommendations of the Advisory Committee on Immunization Practices (ACIP).
    Fischer M; Lindsey N; Staples JE; Hills S;
    MMWR Recomm Rep; 2010 Mar; 59(RR-1):1-27. PubMed ID: 20224546
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Japanese encephalitis: defining risk incidence for travelers to endemic countries and vaccine prescribing from the UK and Switzerland.
    Hatz C; Werlein J; Mutsch M; Hufnagel M; Behrens RH
    J Travel Med; 2009; 16(3):200-3. PubMed ID: 19538582
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Overview of Japanese encephalitis disease and its prevention. Focus on IC51 vaccine (IXIARO
    Amicizia D; Zangrillo F; Lai PL; Iovine M; Panatto D
    J Prev Med Hyg; 2018 Mar; 59(1):E99-E107. PubMed ID: 29938245
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characteristics of Travelers to Asia Requiring Multidose Vaccine Schedules: Japanese Encephalitis and Rabies Prevention.
    Walker XJ; Barnett ED; Wilson ME; Macleod WB; Jentes ES; Karchmer AW; Hamer DH; Chen LH;
    J Travel Med; 2015; 22(6):403-9. PubMed ID: 26420372
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A single dose of vero cell-derived Japanese encephalitis (JE) vaccine (Ixiaro) effectively boosts immunity in travelers primed with mouse brain-derived JE vaccines.
    Erra EO; Askling HH; Rombo L; Riutta J; Vene S; Yoksan S; Lindquist L; Pakkanen SH; Huhtamo E; Vapalahti O; Kantele A
    Clin Infect Dis; 2012 Sep; 55(6):825-34. PubMed ID: 22696017
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Travel-acquired Japanese encephalitis and vaccination considerations.
    Pavli A; Maltezou HC
    J Infect Dev Ctries; 2015 Sep; 9(9):917-24. PubMed ID: 26409731
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Use of Japanese encephalitis vaccine in children: recommendations of the advisory committee on immunization practices, 2013.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2013 Nov; 62(45):898-900. PubMed ID: 24226626
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Perceptions among the U.S. population of value of Japanese encephalitis (JE) vaccination for travel to JE-endemic countries.
    Hills SL; Fischer M; Biggerstaff BJ
    Vaccine; 2020 Feb; 38(9):2117-2121. PubMed ID: 31992482
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cross-protection elicited by primary and booster vaccinations against Japanese encephalitis: a two-year follow-up study.
    Erra EO; Askling HH; Yoksan S; Rombo L; Riutta J; Vene S; Lindquist L; Vapalahti O; Kantele A
    Vaccine; 2013 Dec; 32(1):119-23. PubMed ID: 24176496
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative economic analysis of strategies for Japanese encephalitis vaccination of U.S. travelers.
    Carias C; Hills SL; Kahn EB; Adhikari BB; Fischer M; Meltzer MI
    Vaccine; 2020 Apr; 38(17):3351-3357. PubMed ID: 32169391
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Japanese Encephalitis Vaccine.
    Mileno MD
    R I Med J (2013); 2020 Aug; 103(6):49-50. PubMed ID: 32752568
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Allergic reactions to Japanese encephalitis vaccine.
    Plesner AM
    Immunol Allergy Clin North Am; 2003 Nov; 23(4):665-97. PubMed ID: 14753386
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Japanese Encephalitis Among Three U.S. Travelers Returning from Asia, 2003-2008.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2009 Jul; 58(27):737-40. PubMed ID: 19609246
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Risk assessment for Japanese encephalitis vaccination.
    Turtle L; Driver C
    Hum Vaccin Immunother; 2018 Jan; 14(1):213-217. PubMed ID: 29244615
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inactivated Japanese encephalitis virus vaccine. Recommendations of the Advisory Committee on Immunization Practices (ACIP).
    MMWR Recomm Rep; 1993 Jan; 42(RR-1):1-15. PubMed ID: 8381504
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Vero cell-derived, inactivated, SA14-14-2 strain-based vaccine (Ixiaro) for prevention of Japanese encephalitis.
    Erra EO; Kantele A
    Expert Rev Vaccines; 2015; 14(9):1167-79. PubMed ID: 26162529
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recommendations for use of a booster dose of inactivated vero cell culture-derived Japanese encephalitis vaccine: advisory committee on immunization practices, 2011.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2011 May; 60(20):661-3. PubMed ID: 21617632
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.